menu
    • menu
    [{"orgOrder":0,"company":"ArcherDX, Inc","sponsor":"Merck Group","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Tepotinib","moa":"Hepatocyte growth factor receptor","graph1":"Oncology","graph2":"Approved FDF","graph3":"ArcherDX, Inc","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Tablet, Film Coated","sponsorNew":"ArcherDX, Inc \/ Merck Group","highestDevelopmentStatusID":"15","companyTruncated":"ArcherDX, Inc \/ Merck Group"}]

    Find Clinical Drug Pipeline Developments & Deals by ArcherDX, Inc

    Menu

    ArcherDX, Inc

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            ArcherDX, Inc

                            U.S.A arrow
                            Formnext Forum
                            Not Confirmed

                            ArcherDX, Inc

                            U.S.A arrow
                            Formnext Forum
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tepotinib

                            Therapeutic Area : Oncology

                            Study Phase : Approved FDF

                            Sponsor : Merck Group

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Japan Approves ArcherMET Companion Diagnostic For TEPMETKO

                            Details : Tepmetko (tepotinib) is a kinase inhibitor indicated for the treatment of adult patients with mNSCLC harboring mesenchymal epithelial transition (MET) exon 14 skipping alterations.

                            Product Name : Tepmetko

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            March 25, 2020

                            Lead Product(s) : Tepotinib

                            Therapeutic Area : Oncology

                            Highest Development Status : Approved FDF

                            Sponsor : Merck Group

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth